Join the discussion this Saturday, October 18, 2025, at the Hamburg Auditorium – CityCube A, to explore how AI is driving innovation in precision medicine and drug discovery.
🧠 Session: AI-based procedures to augment clinical trials
🕥 Time: 10:15 – 11:45
The session will feature leading experts in the field, including Dr. Arsela Prelaj (Milan, Italy), who will open the session with her lecture:
🎙️ 10:15 – 10:30 | AI for genomic precision medicine in clinical trials
Chaired by:
👩⚕️ Mihaela Aldea (Villejuif, France)
👨⚕️ Jakob Nikolas Kather (Dresden, Germany)
Today, the PI of this EuropeanProject, Arsela Prelaj, is moderating an Educational Session on AI-based image biomarkers in oncology, radiology and pathology.
📍: Hanover Auditorium – Hall 7.2c
🕐: 14:00 – 15:30
We’re ready for another excellent congress ahead! 🫁🇪🇺
Discover how AI is transforming clinical trials in oncology!
Artificial intelligence is revolutionizing how we design and conduct clinical trials in oncology. On November 6th, leading experts will gather in Rome for “AI in Clinical Trials”, organized by ESAC – European Interdisciplinary Society of AI for Cancer Research, to explore innovative trial designs, trustworthy AI implementation, and real-world data applications.
You can follow the event in person or online.
🔗 To register, click here
Barcelona in early September gave us more than late summer sun, tapas, and strolls by the beach, it gave us WCLC 2025, the biggest global stage for lung cancer research. And this year, I3LUNG showed up with ideas, data, posters, and people ready to shake things up.
The World Conference on Lung Cancer (WCLC), organized by the IASLC, brought together passionate minds and lung cancer experts from around the world, and I3LUNG was right there in the mix. Here’s how we made our mark with five bold moves during the congress.
1. We kicked things off with bold conversations at the IST Innovation Forum on September 6
On day 1 of the Congress, MEDSIR from work package 1 and 10, hosted a side event that got people talking. One of the topics during IST Innovation Forum was how AI can boost innovation in investigator-sponsored trials. Our own Dr. Arsela Prelaj led a thought-provoking session on how data and algorithms are reshaping clinical trials from the inside out.
2. We listened to coughs: yes, coughs, to detect cancer. Poster P1.04.51, on September 7 at 10:30 AM
On Sunday morning, Arsela presented our research on multimodal cough analysis as a pre-screening tool for NSCLC. The idea? Using AI to catch subtle audio and signal patterns in patients’ coughs to detect lung cancer earlier and less invasively. It sparked curiosity. Some attendees stayed and asked questions, intrigued by how something as ordinary as a cough could play a role in early detection.
3. PD-L1 predictions from H&E whole-slides images. Poster P2.06.65, September 8 at 10:30 AM
Vanja Stojanovic, from POLIMI partner, presented our ensemble AI model capable of predicting PD-L1 expression from standard H&E whole-slide images. Translation: fewer extra tests, faster insights, and a new way to support clinical decisions using data we already have.
A great way to start a conversation on how far pathology can go when teamed up with tech. Watch video here.
4. Oral sessions are always a highlight at #WCLC2025!
This oral on “A Multimodal AI-Based Clinical Decision Support System for Predicting Immunotherapy Efficacy in Metastatic NSCLC” marks an important milestone for our project, and we are grateful to all the colleagues and collaborators whose dedication makes every study, every paper, and every presentation possible.
5. We hit the plenary stage and talked big data, big impact. PL04.03, September 9 at 8:30 AM
Yes, the plenary. On Tuesday morning, bright and early, Dr. Arsela Prelaj took the spotlight for “Data-Driven Oncology: How Big Data and AI Can Transform Lung Cancer.”
For 15 minutes, the room was fully tuned in. She painted a clear picture of how multimodal data (spanning clinical records, scans, pathology, and genomics) can help us move from “one-size-fits-all” to personalized, precise, and smarter treatment decisions.
From poster sessions to plenary talks, from after-hours brainstorms to spontaneous reunions with colleagues across Europe and beyond, WCLC 2025 had it all. The I3LUNG team was once again energized and inspired to keep pushing the boundaries of lung cancer care.
See you next year, #WCLC26!
On the final day of #WCLC25, Arsela Prelaj represented #I3LUNG at the Scientific Plenary with her talk: “Data-Driven oncology: how big data and AI can transform lung cancer.”
Being part of such a prestigious session highlights the growing importance of data and AI in the future of lung cancer care, and it was a great opportunity to showcase I3LUNG’s commitment to innovation in thoracic oncology.
👏 Congratulations, Arsela, for this important contribution to the scientific community!
Today marked the first day of the International Association for the Study of Lung Cancer hashtagWCLC25 in Barcelona — and the first item on our agenda 👏🏼
We were proud to see our PI, Arsela Prelaj, take part in the Early Career Investigator Workshop with her session “Using AI Tools to Streamline Presentation Creation”, alongside other international experts.
👏 A great start to an inspiring congress for the I3LUNG project!
Beyond our posters, oral presentation, and plenary talk, we’re excited to share that Arsela Prelaj, will also take part in the Early Career Investigator Workshop – Part 3.
🗓 September 6 – 2:50 PM CEST
📍 WS03.03.04 – Using AI Tools to Streamline Presentation Creation
As Head of AI-ON Lab and PI of I3LUNG, Arsela will highlight how AI enhances both clinical research and scientific communication.
Planning your WCLC Schedule?
👋 See you there!
The countdown is on, and the I3LUNG team has a full agenda during the International Association for the Study of Lung Cancer, taking place September 6-9 in Barcelona. Here’s what we’ll be up to. Swipe through the carousel to see all the highlights! 👇🏼
📍 September 6 – 6 PM CEST
Arsela Prelaj from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano will join, as a speaker, the ISTsInnovationForum organized by MEDSIR, alongside a team of international experts, to discuss how artificial intelligence is transforming oncology clinical trials.
📍September 7 – 10:30 AM CEST
➤ Poster P1.04.51: “Exploring the potential of multimodal cough analisis as a pre-screening tool for non-small cell lung cancer detection”
➤ Session P1.04 – Screening and early detection
Arsela Prelaj will present this study
📍September 8 – 10:30 AM CEST
➤ Poster P2.06.65: “An ensemble approach to predict three-class PD-L1 expression from H&E whole-slide images”
➤ Session P2.06 – Pathology and Biomarkers
Vanja Mišković will present this study
📍 September 8 – 3:30 PM CEST
🚨 ORAL PRESENTATION: one of the highlights of the conference for our project!
➤ “A Multimodal AI-Based Clinical Decision Support System for Predicting Immunotherapy Efficacy in Metastatic NSCLC”
➤ Session OA09.02 – New Advances in Pathology
✨ Don’t miss Arsela Prelaj taking the stage.
📍September 9 – 8:30 AM CEST
🌟 A major highlight: I3LUNG on the Scientific Plenary stage
Arsela Prelaj will take part in the Scientific Plenary with Lectureship Award Presentations, delivering the talk: “Data-Driven Oncology: How big data and AI can transform Lung Cancer”
Planning your WCLC Schedule?
👋 See you there!
Dr. Arsela Prelaj, PI of our I3LUNG project, was invited to the Lung Cancer Considered podcast by International Association for the Study of Lung Cancer to join Dr. Stephen Liu in a conversation about the role of AI in clinical trials, diagnostics, and biomarker analysis, as well as the opportunities and challenges this technology brings to thoracic oncology.
🎧 Listen here!
👏 Arsela never stops! 🚀
Today, we join the global call to raise awareness about lung cancer, one of the world’s leading causes of cancer-related deaths. But awareness is only the beginning…
What if we could predict the best treatment for each patient before the treatment even begins?
At I3LUNG, we are harnessing the power of artificial intelligence and multi-omic data to make personalized immunotherapy decisions a reality for patients with advanced non-small cell lung cancer.
🔬 Precision
🧠 AI
👩⚕️ Patient-centered research
Because when science meets technology, lives can be changed.
